Coagulation Disorder Clinical Trial
Official title:
Effect of Aerobic Exercises on Sex Hormones and Coagulation Factors in Postmenopausal Elderly Women
PURPOSE: to determine the effect of aerobic exercise training on sex hormones and coagulation factors in postmenopausal elderly women BACKGROUND: Cardiovascular disease (CVD) is the largest cause of death in women, and the risk of developing CVD increases after menopause . Because thrombosis is thought to be a cause of most acute cardiovascular events, abnormalities in endogenous coagulation and fibrinolysis may play an important role in the risk of an acute cardiovascular event. Aging is also associated with adverse changes in both coagulation and fibrinolysis. For instance, postmenopausal women exhibit higher fibrinogen levels and lower levels of endogenous fibrinolysis. Physical activity and physical fitness have consistently been linked to lower CVD rates in women. In fact, an inverse association between physical activity and total mortality, as well as a 50% reduction in risk of myocardial infarction, has been observed in physically active postmenopausal women. In addition to the numerous other benefits provided by regular physical activity, one of the mechanisms mediating the cardioprotective effect may be changes in the hemostatic system, particularly fibrinolysis HYPOTHESES: Aerobic exercises may have no effect on sex hormones and coagulation factors in elderly postmenopausal women RESEARCH QUESTION: Do aerobic exercises effect on sex hormones and coagulation factors in elderly postmenopausal women in response to exercises?
Status | Recruiting |
Enrollment | 40 |
Est. completion date | August 20, 2022 |
Est. primary completion date | May 15, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 60 Years to 70 Years |
Eligibility | Inclusion Criteria: - • forty Postmenopausal women (60-70 y) - Body mass index (BMI) ranged from 35 to 39.9 kg/m2 Exclusion Criteria: - • regular medications(e.g., ß-blockers, a-blockers, digoxin, diuretics, aspirin, nitrates, Presently using hormone replacement therapy (HRT) and non steroidal anti-inflammatory drugs, - smoking; - cognitive impairment that will make it difficult to partake in the study - presence of malignant disease - blood donation within the last 6 months - Participation as a subject in any type of study or research during the prior 90 days - hypertension, - having active chronic illness (e.g., rheumatoid arthritis, hyperthyroidism, and inflammatory bowel disease) and diabetes mellitus or other (unstable) endocrine-related diseases - personal history of cardiovascular diseases, - Orthopedic problems inhibiting exercises. |
Country | Name | City | State |
---|---|---|---|
Egypt | Physical Therapy | Cairo |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | coagulation factors | change of selected coagulation factors by blood analysis (plasminogen activator inhibitor-1 ,tissue plasminogen activator ,Prothrombin time ,Partial Thromboplastin time ,fibrinogen ) | 12 weeks | |
Primary | sex hormones | change of (estradiol ,testosterone. sex hormone binding globin ) | 12 weeks | |
Secondary | weight | measuring weight in kilograms | 12 weeks | |
Secondary | height | measuring height in meters | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03826043 -
THrombo-Embolic Event in Onco-hematology
|
N/A | |
Recruiting |
NCT04274777 -
The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
|
||
Recruiting |
NCT03136510 -
Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban
|
N/A | |
Completed |
NCT01588132 -
Anfibatide Phase 1 Clinical Trial in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04524637 -
The Utility of Thromboelastography in Traumatic Brain Injury
|
||
Completed |
NCT03634215 -
Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma
|
||
Completed |
NCT05152420 -
Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects
|
Phase 1 | |
Recruiting |
NCT05645081 -
Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
|
||
Completed |
NCT04322721 -
Coagulopathy on the First Postoperative Day Predicts the Long-term Survival of Traumatic Brain Injury Patients
|
||
Completed |
NCT03267823 -
INR Comparison Testing in Cardiac Surgery
|
||
Completed |
NCT04490759 -
QStat Pilot Reference Range Study
|
||
Completed |
NCT04107818 -
Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients.
|
||
Recruiting |
NCT05484830 -
Coagulation in Acute Aortic Dissection
|
N/A | |
Recruiting |
NCT04111120 -
Heparin Like Effect in Acute Variceal Bleeding
|
||
Completed |
NCT05162339 -
Inflammatory Bowel Disease and Thromboembolic Events
|
||
Completed |
NCT03555630 -
Thromboelastogram in Postdelivery Preeclamptic Patients
|
||
Completed |
NCT01589172 -
Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury
|
||
Recruiting |
NCT04278404 -
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
|
||
Completed |
NCT03956836 -
Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)
|
||
Completed |
NCT06154018 -
Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.
|
N/A |